Physician profile
Nicholas Dangelo
NPI 1396790648
$3,950.63
in general payments reported to CMS, 2019-2025
22 companies · $932 in 2025
The $932 reported for 2025 was more than what 84% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $365 · 2021: $406 · 2022: $257 · 2023: $770 · 2024: $405 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,106.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $708.26 | 2020-2025 | Puraply, Apligraf, Puraply Wound Matrix |
| Abbott Laboratories | $530.70 | 2019-2025 | Esprit |
| Bioventus LLC | $334.20 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $288.93 | 2023-2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Regranex, Collagenase Santyl |
| Angiodynamics, INC. | $179.98 | 2024 | Auryon Laser System 100-120 Vac |
| Stryker Corporation | $165.99 | 2023 | Citrefix |
| Nevro Corp. | $144.43 | 2023 | Senza |
| Wright Medical Technology, INC. | $136.89 | 2020 | |
| Orthofix Medical, INC. | $127.58 | 2019 | |
| Paratek Pharmaceuticals, INC. | $125.00 | 2024 | Nuzyra |
| Allergan, INC. | $125.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $124.38 | 2019 | |
| Stability Biologics, LLC | $123.70 | 2021 | |
| Amgen INC. | $122.21 | 2025 | Krystexxa |
| Treace Medical Concepts, INC. | $121.91 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $121.43 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $121.03 | 2025 | Jublia |
| Biocomposites INC | $100.00 | 2025 | Stimulan |
| Medtronic, INC. | $82.90 | 2023 | Hawkone |
| Celularity INC. | $77.00 | 2019 | |
| Medtronic Vascular, INC. | $76.34 | 2019 | |
| Celgene Corporation | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Dangelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.